Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Katsuda T, Sussman J, Ito K, Katznelson A, Yuan S, Li J, Merrell AJ, Takenaka N, Cure H, Li Q, Rasool RU, Asangani IA, Zaret KS, Stanger BZ. Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity. bioRxiv 2023:2023.02.14.528556. [PMID: 36824858 PMCID: PMC9948957 DOI: 10.1101/2023.02.14.528556] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]

For:	Katsuda T, Sussman J, Ito K, Katznelson A, Yuan S, Li J, Merrell AJ, Takenaka N, Cure H, Li Q, Rasool RU, Asangani IA, Zaret KS, Stanger BZ. Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity. bioRxiv 2023:2023.02.14.528556. [PMID: 36824858 PMCID: PMC9948957 DOI: 10.1101/2023.02.14.528556] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]

Number

Cited by Other Article(s)

Tzouanas CN, Sherman MS, Shay JE, Rubin AJ, Mead BE, Dao TT, Butzlaff T, Mana MD, Kolb KE, Walesky C, Pepe-Mooney BJ, Smith CJ, Prakadan SM, Ramseier ML, Tong EY, Joung J, Chi F, McMahon-Skates T, Winston CL, Jeong WJ, Aney KJ, Chen E, Nissim S, Zhang F, Deshpande V, Lauer GM, Yilmaz ÖH, Goessling W, Shalek AK. Chronic metabolic stress drives developmental programs and loss of tissue functions in non-transformed liver that mirror tumor states and stratify survival. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2023:2023.11.30.569407. [PMID: 38077056 PMCID: PMC10705501 DOI: 10.1101/2023.11.30.569407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/18/2023]

Abstract

Under chronic stress, cells must balance competing demands between cellular survival and tissue function. In metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD/NASH), hepatocytes cooperate with structural and immune cells to perform crucial metabolic, synthetic, and detoxification functions despite nutrient imbalances. While prior work has emphasized stress-induced drivers of cell death, the dynamic adaptations of surviving cells and their functional repercussions remain unclear. Namely, we do not know which pathways and programs define cellular responses, what regulatory factors mediate (mal)adaptations, and how this aberrant activity connects to tissue-scale dysfunction and long-term disease outcomes. Here, by applying longitudinal single-cell multi -omics to a mouse model of chronic metabolic stress and extending to human cohorts, we show that stress drives survival-linked tradeoffs and metabolic rewiring, manifesting as shifts towards development-associated states in non-transformed hepatocytes with accompanying decreases in their professional functionality. Diet-induced adaptations occur significantly prior to tumorigenesis but parallel tumorigenesis-induced phenotypes and predict worsened human cancer survival. Through the development of a multi -omic computational gene regulatory inference framework and human in vitro and mouse in vivo genetic perturbations, we validate transcriptional (RELB, SOX4) and metabolic (HMGCS2) mediators that co-regulate and couple the balance between developmental state and hepatocyte functional identity programming. Our work defines cellular features of liver adaptation to chronic stress as well as their links to long-term disease outcomes and cancer hallmarks, unifying diverse axes of cellular dysfunction around core causal mechanisms.

Collapse

Affiliation(s)

Constantine N. Tzouanas Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Cambridge, MA, USA Broad Institute of MIT and Harvard, Cambridge, MA, USA Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA These authors contributed equally
Marc S. Sherman Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA These authors contributed equally
Jessica E.S. Shay David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA These authors contributed equally
Adam J. Rubin Broad Institute of MIT and Harvard, Cambridge, MA, USA Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA
Benjamin E. Mead Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA Broad Institute of MIT and Harvard, Cambridge, MA, USA Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA
Tyler T. Dao Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA Broad Institute of MIT and Harvard, Cambridge, MA, USA Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
Titus Butzlaff Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Miyeko D. Mana David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA School of Life Sciences, Arizona State University, Tempe, AZ, USA
Kellie E. Kolb Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA Broad Institute of MIT and Harvard, Cambridge, MA, USA Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA
Chad Walesky Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Brian J. Pepe-Mooney Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Cambridge, MA, USA Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA
Colton J. Smith Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Sanjay M. Prakadan Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA Broad Institute of MIT and Harvard, Cambridge, MA, USA Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA
Michelle L. Ramseier Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Cambridge, MA, USA Broad Institute of MIT and Harvard, Cambridge, MA, USA Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA
Evelyn Y. Tong Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Cambridge, MA, USA Broad Institute of MIT and Harvard, Cambridge, MA, USA Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA
Julia Joung Broad Institute of MIT and Harvard, Cambridge, MA, USA Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA Department of Brain and Cognitive Science, MA, Cambridge, MA, USA McGovern Institute for Brain Research at MIT, Cambridge, MA, USA Howard Hughes Medical Institute, MIT, Cambridge, MA, USA Whitehead Institute for Biomedical Research, Cambridge, MA, USA
Fangtao Chi David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA
Thomas McMahon-Skates Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Carolyn L. Winston Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Woo-Jeong Jeong Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Cambridge, MA, USA Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Dana-Farber Cancer Institute, Boston, MA, USA
Katherine J. Aney Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Cambridge, MA, USA Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Dana-Farber Cancer Institute, Boston, MA, USA
Ethan Chen Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Cambridge, MA, USA Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Dana-Farber Cancer Institute, Boston, MA, USA
Sahar Nissim Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Cambridge, MA, USA Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Dana-Farber Cancer Institute, Boston, MA, USA Gastroenterology Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Feng Zhang Broad Institute of MIT and Harvard, Cambridge, MA, USA Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA Department of Brain and Cognitive Science, MA, Cambridge, MA, USA McGovern Institute for Brain Research at MIT, Cambridge, MA, USA Howard Hughes Medical Institute, MIT, Cambridge, MA, USA
Vikram Deshpande Department of Pathology, Massachusetts General Hospital, Boston, MA
Georg M. Lauer Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA
Ömer H. Yilmaz David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA Department of Pathology, Massachusetts General Hospital, Boston, MA These senior authors contributed equally
Wolfram Goessling Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Cambridge, MA, USA Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA Dana-Farber Cancer Institute, Boston, MA, USA Harvard Stem Cell Institute, Cambridge, MA, USA Developmental and Regenerative Biology Program, Harvard Medical School, Boston, MA, USA These senior authors contributed equally
Alex K. Shalek Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Cambridge, MA, USA Broad Institute of MIT and Harvard, Cambridge, MA, USA Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA These senior authors contributed equally

Collapse